Safety of Antiplatelet Therapy in Noncardioembolic Ischemic Stroke With Thrombocytopenia: The CASE II Study
The use of antiplatelet therapy lessened as platelet count decreased in patients with AIS with thrombocytopenia. However, our findings suggest that antiplatelet medications remain safe and effective for this population.
Authors
- Jieming Zhong (ORCID: https://orcid.org/0000-0001-8987-2216)
- Shenqiang Yan (ORCID: https://orcid.org/0000-0001-6425-0672)
- Fujian Chen (ORCID: https://orcid.org/0000-0002-8606-3648)
- Wansi Zhong (ORCID: https://orcid.org/0000-0002-4775-7778)
- Huan‐Xiang Zhou (ORCID: https://orcid.org/0000-0001-9020-0302)
- Min Lou (ORCID: https://orcid.org/0000-0002-6627-064X)
- Tingxia Zhang
- Yu Han (ORCID: https://orcid.org/0000-0003-1462-1118)
- Weiwei Gong (ORCID: https://orcid.org/0000-0002-7066-4772)
- Dongjuan Xu (ORCID: https://orcid.org/0000-0002-0832-7417)
Institutions
- Wenzhou Medical University (CN)
- Zhejiang Center for Disease Control and Prevention (CN)
- Dongyang People's Hospital (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1161/jaha.123.032327
- Citations
- 3
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.21
Funders
- National Natural Science Foundation of China